EP1924574
Ferli til að framleiða 5-(metýl-1H-imídasól-1-ýl)-3-(tríflúorómetýl)-bensamín.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
7.6.2006EP published:
10.11.2010EP application number:
06772448.4
EP translation filed:
10.2.2011Grant published:
15.3.2011EPO information:
European Patent Register
Max expiry date:
6.6.2026Expiry date:
6.6.2018
Title:
PROCESS FOR THE SYNTESIS OF 5-(METHYL-1H-IMIDAZOL-1-YL)-3-(TRI FLUOROME TH YL)-BENZENEAMINE
Timeline
Today
7.6.2006EP application
10.11.2010EP Publication
10.2.2011Translation submitted
15.3.2011Registration published
6.6.2018Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
MCKENNA, JosephAddress:
Nazareth, Pennsylvania, US
Name:
SHIEH, Wen-ChungAddress:
Berkeley Heights, New Jersey, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
688977 PDate:
9.6.2005Country:
US
Number:
705590 PDate:
4.8.2005Country:
US
Classification
Categories:
C07D 401/04
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 4.5.2011
Expires: 6.6.2012
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 7.5.2012
Expires: 6.6.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.5.2013
Expires: 6.6.2014
Payer: Árnason Faktor
Number: 9
Paid: 7.5.2014
Expires: 6.6.2015
Payer: Árnason Faktor
Number: 10
Paid: 7.5.2015
Expires: 6.6.2016
Payer: Árnason Faktor
Number: 11
Paid: 10.5.2016
Expires: 6.6.2017
Payer: Árnason Faktor
Number: 12
Paid: 26.5.2017
Expires: 6.6.2018
Payer: Árnason Faktor